Compounds > bazedoxifene
Page last updated: 2024-09-04

bazedoxifene and Uterine Hemorrhage

bazedoxifene has been researched along with Uterine Hemorrhage in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, L; Bobula, J; Bushmakin, AG; Komm, BS; Lavenberg, J; Pinkerton, JV1
Abreu, P; Andrews, E; Kagan, R1
Choi, D; Kim, SE; Lee, DY1
Currie, H; Dragon, E; Mikkola, TS; Palacios, S1
Archer, DF; Kagan, R; Komm, BS; Mirkin, S; Pan, K; Pickar, JH; Pinkerton, JV; Thompson, JR1
Archer, DF; Carr, BR; Lewis, V; Olivier, S; Pickar, JH1

Reviews

1 review(s) available for bazedoxifene and Uterine Hemorrhage

ArticleYear
Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Maturitas, 2015, Volume: 80, Issue:4

    Topics: Adult; Amenorrhea; Bone Density; Breast; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Hemorrhage; Venous Thromboembolism

2015

Trials

4 trial(s) available for bazedoxifene and Uterine Hemorrhage

ArticleYear
Time to first occurrence of breast pain and vaginal bleeding in phase 3 trials of CE/BZA.
    Menopause (New York, N.Y.), 2017, Volume: 24, Issue:12

    Topics: Adult; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Mastodynia; Menopause; Middle Aged; Placebos; Selective Estrogen Receptor Modulators; Time Factors; Uterine Hemorrhage

2017
Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
    Postgraduate medicine, 2018, Volume: 130, Issue:8

    Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Uterine Hemorrhage

2018
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
    Journal of women's health (2002), 2016, Volume: 25, Issue:5

    Topics: Bone Density; Bone Density Conservation Agents; Breast; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Selective Estrogen Receptor Modulators; Uterine Hemorrhage

2016
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
    Fertility and sterility, 2009, Volume: 92, Issue:3

    Topics: Adult; Aged; Amenorrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Middle Aged; Outpatients; Postmenopause; Selective Estrogen Receptor Modulators; Treatment Outcome; Uterine Hemorrhage

2009

Other Studies

1 other study(ies) available for bazedoxifene and Uterine Hemorrhage

ArticleYear
Tissue-selective estrogen complex for women who experience breast discomfort or vaginal bleeding when on hormone therapy.
    Menopause (New York, N.Y.), 2019, Volume: 26, Issue:4

    Topics: Cohort Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Mastodynia; Middle Aged; Postmenopause; Retrospective Studies; Selective Estrogen Receptor Modulators; Uterine Hemorrhage

2019